Back
Speaker illustration

Doctor Meixian Chen

Fujian Medical University, Fuzhou (China)

Presentations

If current inhibitor ivabradine reduces 2-year hospital readmission risk of patients with heart failure: a retrospective cohort study

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 2

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources